Akaza Eriko | Department Of Ophthalmology Nihon University Surugadai Hospital
スポンサーリンク
概要
関連著者
-
Mori Ryusaburo
Department Of Ophthalmology Nihon University School Of Medicine Surugadai Hospital Of Nihon Universi
-
Yuzawa Mitsuko
Department Of Ophthalmology Nihon University Hospital
-
Akaza Eriko
Department Of Ophthalmology Nihon University Surugadai Hospital
-
Akaza Eriko
Department Of Ophthalmology Surugadai Hospital Of Nihon University
-
Yuzawa M
Department Of Ophthalmology Nihon University School Of Medicine Surugadai Hospital Of Nihon Universi
-
Yuzawa Mitsuko
Department Of Ophthalmology Surugadai Hospital Of Nihon University
-
Mori Ryusaburo
日本大学 医学部眼科学
-
Mori R
Department Of Ophthalmology Nihon University School Of Medicine Surugadai Hospital Of Nihon Universi
-
YUZAWA Mitsuko
Department of Ophthalmology, School of Medicine, Nihon University
-
Mori Ryusaburo
Department Of Ophthalmology School Of Medicine Nihon University
-
FUJITA Kyoko
Department of Biotechnology, Tokyo University of Agriculture and Technology
-
MATSUMOTO Yoko
Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo
-
Fujita Kyoko
和歌山県立医科大学 医学部眼科学教室
-
Fujita Kyoko
Department Of Biotechnology Tokyo University Of Agriculture And Technology
-
Matsumoto Yoko
Department Of Obstetrics And Gynecology Graduate School Of Medicine The University Of Tokyo
-
Haruyama Miho
Department Of Ophthalmology Nihon University School Of Medicine
-
KASHIWAKURA Shiho
Department of Ophthalmology, Surugadai Hospital of Nihon University
-
Kashiwakura Shiho
Department Of Ophthalmology Surugadai Hospital Of Nihon University
-
Matsumoto Yoko
Department Of Ophthalmology Surugadai Hospital Of Nihon University
-
Matsumoto Yoko
Department Of Industrial Chemistry Faculty Of Engineering Kumamoto Institute Of Technology
-
AKAZA Eriko
Department of Ophthalmology, School of Medicine, Surugadai Nihon University Hospital
著作論文
- Role of Photodynamic Therapy in Polypoidal Choroidal Vasculopathy
- Three-Year Follow-up Results of Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
- Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity